The Ministry of Finance (MOF) has released an updated notification regarding technologies banned and restricted from export from China. The update includes the removal of 32 items, revision of 36 items, and the addition of 7 new items. The list now comprises 24 technologies prohibited from export and 115 with applied restrictions.
Life Sciences Technologies Affected
In the life sciences sector, technologies banned from export include those used for human cell cloning and gene editing. Specifically, the list includes:
- Somatic cell cloning technology, covering nuclear extraction and removal, nuclear transfer, embryo transfer, and key enzymes for cell activation.
- Human gene editing technologies, including ZFN, TALEN, and CRISPR technologies, specific nucleases, homologous recombination, point knockout, gene introduction, fragment deletion, and multi-site mutation technologies.
The MOF has specifically prohibited the export of CRISPR technology applied in ethically controversial areas, such as gene editing in embryonic cells, egg cells, and sperm cells, or other areas with potential serious consequences during research.-Fineline Info & Tech
